KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Return on Sales (2017 - 2025)

Sarepta Therapeutics (SRPT) has 13 years of Return on Sales data on record, last reported at 0.21% in Q4 2025.

  • For Q4 2025, Return on Sales rose 28.0% year-over-year to 0.21%; the TTM value through Dec 2025 reached 0.21%, up 4.0%, while the annual FY2024 figure was 1.25%, 149.0% up from the prior year.
  • Return on Sales reached 0.21% in Q4 2025 per SRPT's latest filing, up from 0.7% in the prior quarter.
  • Across five years, Return on Sales topped out at 1.95% in Q4 2022 and bottomed at 11.46% in Q3 2022.
  • Average Return on Sales over 5 years is 0.88%, with a median of 0.15% recorded in 2021.
  • Peak YoY movement for Return on Sales: plummeted -1125bps in 2022, then soared 964bps in 2023.
  • A 5-year view of Return on Sales shows it stood at 1.09% in 2021, then soared by 279bps to 1.95% in 2022, then plummeted by -68bps to 0.61% in 2023, then tumbled by -110bps to 0.06% in 2024, then soared by 430bps to 0.21% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 0.21% in Q4 2025, 0.7% in Q3 2025, and 0.25% in Q2 2025.